Related Experiment Video
Updated: Aug 14, 2026

Co-culture of Living Microbiome with Microengineered Human Intestinal Villi in a Gut-on-a-Chip Microfluidic Device
Published on: August 30, 2016
Gut-on-a-Chip: From Biomimetic Design to Precision Biomedical Applications
Qianqian Lin1,2, Fengshan Zhou1, Wenshuai Hao1,2
1Beijing Key Laboratory of Materials Utilization of Nonmetallic Minerals and Solid Wastes, National Laboratory of Mineral Materials, School of Materials Science and Technology, China University of Geosciences (Beijing), No. 29 Xueyuan Road, Haidian District, Beijing100083, P. R. China.
Gut-on-a-chip (GOC) platforms mimic the human gut using advanced biomaterials and design. This review covers GOC innovations, applications in disease modeling, and future challenges for clinical translation.
Area of Science:
- Biomedical Engineering
- Tissue Engineering
- Microfluidics
Background:
- Gut-on-a-chip (GOC) platforms offer biomimetic environments to study human intestine physiology.
- These systems integrate microfluidics, biomaterials, and cellular components for advanced research.
Purpose of the Study:
- To review biomaterials and design innovations in GOC systems.
- To explore GOC applications in disease modeling, drug evaluation, and personalized medicine.
- To identify key challenges for GOC advancement and clinical translation.
Main Methods:
- Review of biomaterials used in GOC construction.
- Analysis of microfluidic innovations, organoid integration, vascularization, and 3D bioprinting.
- Examination of epithelial barrier function assessment strategies.
Main Results:
- GOC platforms enable recapitulation of gut physiology with enhanced biomimicry.
- Innovations include organoid integration, vascularization, and 3D bioprinting for improved models.
- Applications span disease modeling, nanoformulation testing, personalized medicine, and gut-organ interaction studies.
Conclusions:
- GOC technology holds significant promise for various biomedical applications.
- Addressing challenges in material optimization, standardization, and scalability is crucial for clinical translation.
- Further development is needed for real-time monitoring, data analysis, and cost-effectiveness.

